-
The how and why of living with limb-girdle muscular dystrophy
“He who has a why to live can bear almost any how.” — Friedrich Nietzsche I
-
Employer Matching Programs Double the Impact
Anybody who has made a monetary donation to support MDA’s mission knows well that their
-
Agamree : un premier traitement approuvé au Canada pour la DMD
Le 25 septembre 2025, Santé Canada a franchi une étape historique en approuvant AGAMREE® (vamorolone)
-
Just another Monday: Watch movie, do laundry, throw out my back
Mondays are one of my favorite days of the week as a busy mom to
-
CureDuchenne Cares Webinar: Optimizing Cardiac Outcomes in Duchenne
CureDuchenne and Andreas S. Barth, MD, PhD, FAHA, for a community webinar about Optimizing Cardiac
-
Motor function linked to weight, height changes in boys with DMD
For boys who start corticosteroids to treat Duchenne muscular dystrophy (DMD), being taller is linked
-
MDA Ambassador Guest Blog: Entrepreneurship, Advocacy, and Innovation: Building a More Accessible Future from the Inside Out
Owen Kent is the co-founder and Chief Marketing Officer of Assistive Technology Development (ATDev), a
-
MDA Ambassador Guest Blog: Helpful Tips for Accessible Halloween Costumes
Megan Jennings, known professionally as Sybil Thorn, is an artist and freelance creator. Born with
-
At 45, I’m aware of the many turns along my Duchenne MD path
In recognition of Duchenne Muscular Dystrophy Awareness Month in September, the Duchenne Muscular Dystrophy Community
-
Satellos asks FDA to clear Phase 2 trial of DMD treatment
Satellos Bioscience asked the U.S. Food and Drug Administration (FDA) for clearance to conduct a
